Khalid El Bairi
Khalid El Bairi/LinkedIn

Khalid El Bairi: How to Critically Appraise Randomized Controlled Trials

Khalid El Bairi, Founder of The Cancer Biomarkers Working Group, shared a post on LinkedIn:

”Interested in learning how to critically appraise RCTs? Join us on 27 August for a webinar by the education and training committee of the AORTIC- Africa which will be focused on this important topic and presented by Omar Abdihamid, a former CSO fellow and clinical oncologist.”

Khalid El Bairi

More post featuring Khalid El Bairi on OncoDaily.